Acadia Healthcare Company, Inc.
ACHC Real Time Price USDRecent trades of ACHC by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Susie Lee House / D | Sale $1,001 - $15,000 | Nov. 30, 2022 |
| Peter Meijer House / R | Sale $1,001 - $15,000 | Feb. 16, 2021 |
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ACHC's directors and management
Government lobbying spending instances
-
$60,000 Oct 20, 2024 Issue: Health Issues
-
$60,000 Jul 22, 2024 Issue: Health Issues
-
$60,000 Apr 19, 2024 Issue: Health Issues
-
$60,000 Oct 16, 2023 Issue: Health Issues
-
$95,000 Oct 13, 2023 Issue: Medicare/Medicaid
-
$95,000 Aug 28, 2023 Issue: Medicare/Medicaid
-
$60,000 Jul 11, 2023 Issue: Health Issues
-
$95,000 Apr 26, 2023 Issue: Medicare/Medicaid
-
$60,000 Apr 20, 2023 Issue: Health Issues
-
$95,000 Feb 23, 2023 Issue: Medicare/Medicaid
-
$95,000 Nov 01, 2022 Issue: Medicare/Medicaid
-
$20,000 Oct 20, 2022 Issue: Health Issues
-
$47,500 Aug 08, 2022 Issue: Medicare/Medicaid
-
$50,000 Jul 20, 2022 Issue: Health Issues
-
$47,500 Apr 25, 2022 Issue: Medicare/Medicaid
-
$50,000 Apr 20, 2022 Issue: Health Issues
-
$47,500 Mar 07, 2022 Issue: Medicare/Medicaid
-
$20,000 Jan 18, 2022 Issue: Health Issues
-
$47,500 Nov 03, 2021 Issue: Medicare/Medicaid
-
$20,000 Oct 23, 2021 Issue: Health Issues
-
$20,000 Jul 22, 2021 Issue: Health Issues
-
$47,500 Jul 01, 2021 Issue: Medicare/Medicaid
-
$20,000 Apr 20, 2021 Issue: Health Issues
-
$20,000 Jan 20, 2021 Issue: Health Issues
-
$20,000 Oct 20, 2020 Issue: Health Issues
-
$20,000 Jul 20, 2020 Issue: Health Issues
-
$20,000 Apr 21, 2020 Issue: Health Issues
-
$20,000 Jan 21, 2020 Issue: Health Issues
-
$20,000 Oct 18, 2019 Issue: Health Issues
-
$20,000 Jul 12, 2019 Issue: Health Issues
-
$20,000 Apr 04, 2019 Issue: Medicare/Medicaid Health Issues
-
$20,000 Jan 09, 2019 Issue: Health Issues Medicare/Medicaid
-
$20,000 Oct 10, 2018 Issue: Medicare/Medicaid Health Issues
-
$20,000 Jul 09, 2018 Issue: Health Issues Medicare/Medicaid
-
$20,000 Apr 06, 2018 Issue: Medicare/Medicaid Health Issues
-
$15,000 Jan 12, 2018 Issue: Alcohol and Drug Abuse Taxation/Internal Revenue Code Medicare/Medicaid
-
$15,000 Oct 13, 2017 Issue: Medicare/Medicaid Alcohol and Drug Abuse Health Issues
-
$15,000 Jul 03, 2017 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
- $0 2024-04-25 00:00:00 Agency: Department of Justice
- $0 2024-04-08 00:00:00 Agency: Department of Justice
- $0 2024-04-03 00:00:00 Agency: Department of Justice
- $0 2024-02-29 00:00:00 Agency: Department of Justice
- $0 2024-01-30 00:00:00 Agency: Department of Justice
- $0 2023-11-14 00:00:00 Agency: Department of Justice
- $236,338 2021-06-03 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $270,100 2020-06-24 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
Estimated quarterly amount awarded from public contracts
Number of mentions of ACHC in WallStreetBets Daily Discussion
Recent insights relating to ACHC
Recent picks made for ACHC stock on CNBC
ETFs with the largest estimated holdings in ACHC
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ACHC Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.